Literature DB >> 10085068

Cloning and characterization of a mammalian prenyl protein-specific protease.

J C Otto1, E Kim, S G Young, P J Casey.   

Abstract

Proteins containing C-terminal "CAAX" sequence motifs undergo three sequential post-translational processing steps: modification of the cysteine with either a 15-carbon farnesyl or 20-carbon geranylgeranyl isoprenyl lipid, proteolysis of the C-terminal -AAX tripeptide, and methylation of the carboxyl group of the now C-terminal prenylcysteine. A putative prenyl protein protease in yeast, designated Rce1p, was recently identified. In this study, a portion of a putative human homologue of RCE1 (hRCE1) was identified in a human expressed sequence tag data base, and the corresponding cDNA was cloned. Expression of hRCE1 was detected in all tissues examined. Both yeast and human RCE1 proteins were produced in Sf9 insect cells by infection with a recombinant baculovirus; membrane preparations derived from the infected Sf9 cells exhibited a high level of prenyl protease activity. Recombinant hRCE1 so produced recognized both farnesylated and geranylgeranylated proteins as substrates, including farnesyl-Ki-Ras, farnesyl-N-Ras, farnesyl-Ha-Ras, and the farnesylated heterotrimeric G protein Ggamma1 subunit, as well as geranylgeranyl-Ki-Ras and geranylgeranyl-Rap1b. The protease activity of hRCE1 activity was specific for prenylated proteins, because unprenylated peptides did not compete for enzyme activity. hRCE1 activity was also exquisitely sensitive to a prenyl peptide analogue that had been previously described as a potent inhibitor of the prenyl protease activity in mammalian tissues. These data indicate that both the yeast and the human RCE1 gene products are bona fide prenyl protein proteases and suggest that they play a major role in the processing of CAAX-type prenylated proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085068     DOI: 10.1074/jbc.274.13.8379

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway.

Authors:  D W End
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

2.  Amide-modified prenylcysteine based Icmt inhibitors: Structure-activity relationships, kinetic analysis and cellular characterization.

Authors:  Jaimeen D Majmudar; Heather B Hodges-Loaiza; Kalub Hahne; James L Donelson; Jiao Song; Liza Shrestha; Marietta L Harrison; Christine A Hrycyna; Richard A Gibbs
Journal:  Bioorg Med Chem       Date:  2011-11-06       Impact factor: 3.641

3.  Photoaffinity labeling of Ras converting enzyme using peptide substrates that incorporate benzoylphenylalanine (Bpa) residues: improved labeling and structural implications.

Authors:  Kelly Kyro; Surya P Manandhar; Daniel Mullen; Walter K Schmidt; Mark D Distefano
Journal:  Bioorg Med Chem       Date:  2011-10-18       Impact factor: 3.641

4.  Fighting cancer by disrupting C-terminal methylation of signaling proteins.

Authors:  Steven Clarke; Fuyuhiko Tamanoi
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

5.  Photoaffinity labeling of Ras converting enzyme 1 (Rce1p) using a benzophenone-containing peptide substrate.

Authors:  Kelly Kyro; Surya P Manandhar; Daniel Mullen; Walter K Schmidt; Mark D Distefano
Journal:  Bioorg Med Chem       Date:  2010-06-12       Impact factor: 3.641

Review 6.  Posttranslational Modifications of RAS Proteins.

Authors:  Ian Ahearn; Mo Zhou; Mark R Philips
Journal:  Cold Spring Harb Perspect Med       Date:  2018-11-01       Impact factor: 6.915

7.  K-ras4B and prenylated proteins lacking "second signals" associate dynamically with cellular membranes.

Authors:  John R Silvius; Pinkesh Bhagatji; Rania Leventis; Donato Terrone
Journal:  Mol Biol Cell       Date:  2005-10-19       Impact factor: 4.138

8.  Multiple sequence elements facilitate Chp Rho GTPase subcellular location, membrane association, and transforming activity.

Authors:  Emily J Chenette; Natalia Y Mitin; Channing J Der
Journal:  Mol Biol Cell       Date:  2006-04-26       Impact factor: 4.138

9.  Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect.

Authors:  Martin O Bergo; Bryant Gavino; Jed Ross; Walter K Schmidt; Christine Hong; Lonnie V Kendall; Andreas Mohr; Margarita Meta; Harry Genant; Yebin Jiang; Erik R Wisner; Nicholas Van Bruggen; Richard A D Carano; Susan Michaelis; Stephen M Griffey; Stephen G Young
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

10.  Farnesylation of retinal transducin underlies its translocation during light adaptation.

Authors:  Hidetoshi Kassai; Atsu Aiba; Kazuki Nakao; Kenji Nakamura; Motoya Katsuki; Wei-Hong Xiong; King-Wai Yau; Hiroo Imai; Yoshinori Shichida; Yoshinori Satomi; Toshifumi Takao; Toshiyuki Okano; Yoshitaka Fukada
Journal:  Neuron       Date:  2005-08-18       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.